Nesidioblastosis following laparoscopic sleeve gastrectomy

Albert Kim; Jennifer R. Snaith; Hema Mahajan; Deborah Jane Holmes-Walker

doi:10.1111/cen.14083

Nesidioblastosis following laparoscopic sleeve gastrectomy

Albert Kim, Jennifer R. Snaith, Hema Mahajan, Deborah Jane Holmes-Walker

Western Sydney University

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Hyperinsulinaemic hypoglycaemia due to nesidioblastosis after bariatric surgery is a rare but well‐documented complication of rouxen‐ Y gastric bypass (RYGB). We report the first documented case of nesidioblastosis following laparoscopic sleeve gastrectomy. This is a timely report as sleeve gastrectomy is now the most commonly performed bariatric procedure, accounting for 52.5% of bariatric procedures performed in Australia between 2014 and 2015.1 This case is important as nesidioblastosis is not a previously reported complication of sleeve gastrectomy. It therefore expands our understanding of the effect of surgically induced changes to incretin secretion following sleeve gastrectomy.

Original language	English
Pages (from-to)	906-908
Number of pages	3
Journal	Clinical Endocrinology
Volume	91
Issue number	6
DOIs	https://doi.org/10.1111/cen.14083
Publication status	Published - 2019

Keywords

gastrectomy
hypoglycaemia
obesity
surgery

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/cen.14083

Cite this

@article{1be64f8f1343498fb2139f18a2e749a6,

title = "Nesidioblastosis following laparoscopic sleeve gastrectomy",

abstract = "Hyperinsulinaemic hypoglycaemia due to nesidioblastosis after bariatric surgery is a rare but well‐documented complication of rouxen‐ Y gastric bypass (RYGB). We report the first documented case of nesidioblastosis following laparoscopic sleeve gastrectomy. This is a timely report as sleeve gastrectomy is now the most commonly performed bariatric procedure, accounting for 52.5% of bariatric procedures performed in Australia between 2014 and 2015.1 This case is important as nesidioblastosis is not a previously reported complication of sleeve gastrectomy. It therefore expands our understanding of the effect of surgically induced changes to incretin secretion following sleeve gastrectomy.",

keywords = "gastrectomy, hypoglycaemia, obesity, surgery",

author = "Albert Kim and Snaith, {Jennifer R.} and Hema Mahajan and Holmes-Walker, {Deborah Jane}",

year = "2019",

doi = "10.1111/cen.14083",

language = "English",

volume = "91",

pages = "906--908",

journal = "Clinical Endocrinology",

issn = "0300-0664",

publisher = "Wiley-Blackwell Publishing",

number = "6",

}

TY - JOUR

T1 - Nesidioblastosis following laparoscopic sleeve gastrectomy

AU - Kim, Albert

AU - Snaith, Jennifer R.

AU - Mahajan, Hema

AU - Holmes-Walker, Deborah Jane

PY - 2019

Y1 - 2019

N2 - Hyperinsulinaemic hypoglycaemia due to nesidioblastosis after bariatric surgery is a rare but well‐documented complication of rouxen‐ Y gastric bypass (RYGB). We report the first documented case of nesidioblastosis following laparoscopic sleeve gastrectomy. This is a timely report as sleeve gastrectomy is now the most commonly performed bariatric procedure, accounting for 52.5% of bariatric procedures performed in Australia between 2014 and 2015.1 This case is important as nesidioblastosis is not a previously reported complication of sleeve gastrectomy. It therefore expands our understanding of the effect of surgically induced changes to incretin secretion following sleeve gastrectomy.

AB - Hyperinsulinaemic hypoglycaemia due to nesidioblastosis after bariatric surgery is a rare but well‐documented complication of rouxen‐ Y gastric bypass (RYGB). We report the first documented case of nesidioblastosis following laparoscopic sleeve gastrectomy. This is a timely report as sleeve gastrectomy is now the most commonly performed bariatric procedure, accounting for 52.5% of bariatric procedures performed in Australia between 2014 and 2015.1 This case is important as nesidioblastosis is not a previously reported complication of sleeve gastrectomy. It therefore expands our understanding of the effect of surgically induced changes to incretin secretion following sleeve gastrectomy.

KW - gastrectomy

KW - hypoglycaemia

KW - obesity

KW - surgery

UR - https://hdl.handle.net/1959.7/uws:53613

U2 - 10.1111/cen.14083

DO - 10.1111/cen.14083

M3 - Article

SN - 0300-0664

VL - 91

SP - 906

EP - 908

JO - Clinical Endocrinology

JF - Clinical Endocrinology

IS - 6

ER -

Nesidioblastosis following laparoscopic sleeve gastrectomy

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this